CD9 marks myeloid/MegE-biased human hematopoiesis
F. Safi, P. Dhapola, M. N. E. Sommarin, G. Karlsson
The paper investigates CD9 expression in human hematopoietic stem and progenitor cells (HSPCs) over time, finding that CD9 marks progenitors with high proliferation capacity and is upregulated during myeloid/MegE-biased hematopoiesis.
bioRxiv · Sep 6, 2023 · PreprintCell Biology